AstraZeneca Promises to Reduce Hypertension in Africa
To mark the World Hypertension Day, AstraZeneca, a global science-led pharmaceutical organisation, has committed itself to addressing the hypertension burden in Africa.
“In Africa, less than 10 per cent of the 80 million patients have access to treatment and will continue the crusade by supporting the development of Healthy Heart Africa.”
Mr Tarek Rabah, the Area Vice President of AstraZeneca, Middle East and Africa, in a statement copied to the Ghana News Agency on Tuesday, said Healthy Heart Africa would strengthen healthcare capabilities to provide life-long care for patients living with hypertension as part of the campaign launched in Kenya on Tuesday.
Healthy Heart Africa is AstraZeneca’s access programme aimed at tackling the burden of hypertension and reducing cardiovascular related deaths with a goal to reaching 10 million patients across Sub-Saharan Africa by 2025.
- Health Care